nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Prednisone—chronic obstructive pulmonary disease	0.286	0.506	CrCtD
Exemestane—Prednisolone—chronic obstructive pulmonary disease	0.279	0.494	CrCtD
Exemestane—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0295	0.282	CbGbCtD
Exemestane—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.027	0.109	CrCrCtD
Exemestane—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0264	0.106	CrCrCtD
Exemestane—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.0236	0.0951	CrCrCtD
Exemestane—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.0225	0.0905	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.0225	0.0905	CrCrCtD
Exemestane—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.0219	0.0883	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.0219	0.0883	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.021	0.0846	CrCrCtD
Exemestane—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.0206	0.0828	CrCrCtD
Exemestane—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.0825	CrCrCtD
Exemestane—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0205	0.0825	CrCrCtD
Exemestane—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0199	0.19	CbGbCtD
Exemestane—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.019	0.182	CbGbCtD
Exemestane—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.017	0.162	CbGbCtD
Exemestane—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00995	0.0949	CbGbCtD
Exemestane—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0094	0.0897	CbGbCtD
Exemestane—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000455	0.0993	CbGpPWpGaD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000402	0.0878	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.000364	0.0796	CbGpPWpGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000329	0.0718	CbGpPWpGaD
Exemestane—Estropipate—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.207	CrCbGaD
Exemestane—Estrone—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.133	CrCbGaD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.0365	CbGpPWpGaD
Exemestane—Conjugated Estrogens—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.129	CrCbGaD
Exemestane—Estrone—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.129	CrCbGaD
Exemestane—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00215	CcSEcCtD
Exemestane—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00214	CcSEcCtD
Exemestane—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00214	CcSEcCtD
Exemestane—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00213	CcSEcCtD
Exemestane—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00212	CcSEcCtD
Exemestane—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.0021	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00208	CcSEcCtD
Exemestane—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00206	CcSEcCtD
Exemestane—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00206	CcSEcCtD
Exemestane—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00205	CcSEcCtD
Exemestane—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00205	CcSEcCtD
Exemestane—Estropipate—ALB—chronic obstructive pulmonary disease	0.000154	0.119	CrCbGaD
Exemestane—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00203	CcSEcCtD
Exemestane—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00203	CcSEcCtD
Exemestane—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00203	CcSEcCtD
Exemestane—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.00201	CcSEcCtD
Exemestane—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00198	CcSEcCtD
Exemestane—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00197	CcSEcCtD
Exemestane—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00197	CcSEcCtD
Exemestane—Cough—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00197	CcSEcCtD
Exemestane—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00195	CcSEcCtD
Exemestane—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00195	CcSEcCtD
Exemestane—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00195	CcSEcCtD
Exemestane—Cough—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00193	CcSEcCtD
Exemestane—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00192	CcSEcCtD
Exemestane—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00191	CcSEcCtD
Exemestane—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00188	CcSEcCtD
Exemestane—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00188	CcSEcCtD
Exemestane—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00187	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00187	CcSEcCtD
Exemestane—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00186	CcSEcCtD
Exemestane—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00186	CcSEcCtD
Exemestane—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00184	CcSEcCtD
Exemestane—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00184	CcSEcCtD
Exemestane—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00184	CcSEcCtD
Exemestane—Infection—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00183	CcSEcCtD
Exemestane—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00183	CcSEcCtD
Exemestane—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00181	CcSEcCtD
Exemestane—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00181	CcSEcCtD
Exemestane—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00181	CcSEcCtD
Exemestane—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00181	CcSEcCtD
Exemestane—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00181	CcSEcCtD
Exemestane—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000137	0.0018	CcSEcCtD
Exemestane—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.0018	CcSEcCtD
Exemestane—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.0018	CcSEcCtD
Exemestane—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000137	0.0018	CcSEcCtD
Exemestane—Infection—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00179	CcSEcCtD
Exemestane—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00179	CcSEcCtD
Exemestane—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00179	CcSEcCtD
Exemestane—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00178	CcSEcCtD
Exemestane—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00177	CcSEcCtD
Exemestane—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00176	CcSEcCtD
Exemestane—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00175	CcSEcCtD
Exemestane—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00174	CcSEcCtD
Exemestane—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00173	CcSEcCtD
Exemestane—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00171	CcSEcCtD
Exemestane—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00171	CcSEcCtD
Exemestane—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.0017	CcSEcCtD
Exemestane—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00169	CcSEcCtD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000128	0.028	CbGpPWpGaD
Exemestane—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00168	CcSEcCtD
Exemestane—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00168	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00168	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00168	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.0277	CbGpPWpGaD
Exemestane—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00166	CcSEcCtD
Exemestane—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00166	CcSEcCtD
Exemestane—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00166	CcSEcCtD
Exemestane—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.00165	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00164	CcSEcCtD
Exemestane—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00164	CcSEcCtD
Exemestane—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00164	CcSEcCtD
Exemestane—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00163	CcSEcCtD
Exemestane—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00162	CcSEcCtD
Exemestane—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00162	CcSEcCtD
Exemestane—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00162	CcSEcCtD
Exemestane—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00161	CcSEcCtD
Exemestane—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000121	0.0016	CcSEcCtD
Exemestane—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00159	CcSEcCtD
Exemestane—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00159	CcSEcCtD
Exemestane—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00159	CcSEcCtD
Exemestane—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00159	CcSEcCtD
Exemestane—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00159	CcSEcCtD
Exemestane—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00159	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00158	CcSEcCtD
Exemestane—Pain—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00157	CcSEcCtD
Exemestane—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00156	CcSEcCtD
Exemestane—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00156	CcSEcCtD
Exemestane—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Exemestane—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00155	CcSEcCtD
Exemestane—Pain—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00154	CcSEcCtD
Exemestane—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00154	CcSEcCtD
Exemestane—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.00154	CcSEcCtD
Exemestane—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00153	CcSEcCtD
Exemestane—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00153	CcSEcCtD
Exemestane—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00153	CcSEcCtD
Exemestane—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.00152	CcSEcCtD
Exemestane—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.00152	CcSEcCtD
Exemestane—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00152	CcSEcCtD
Exemestane—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00152	CcSEcCtD
Exemestane—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.00151	CcSEcCtD
Exemestane—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00151	CcSEcCtD
Exemestane—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00151	CcSEcCtD
Exemestane—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000114	0.00151	CcSEcCtD
Exemestane—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.0015	CcSEcCtD
Exemestane—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000114	0.0015	CcSEcCtD
Exemestane—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.0015	CcSEcCtD
Exemestane—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.0015	CcSEcCtD
Exemestane—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00149	CcSEcCtD
Exemestane—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00149	CcSEcCtD
Exemestane—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00147	CcSEcCtD
Exemestane—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00147	CcSEcCtD
Exemestane—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00146	CcSEcCtD
Exemestane—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00146	CcSEcCtD
Exemestane—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00145	CcSEcCtD
Exemestane—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00145	CcSEcCtD
Exemestane—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00145	CcSEcCtD
Exemestane—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00145	CcSEcCtD
Exemestane—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00145	CcSEcCtD
Exemestane—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00144	CcSEcCtD
Exemestane—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.00144	CcSEcCtD
Exemestane—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.00144	CcSEcCtD
Exemestane—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00143	CcSEcCtD
Exemestane—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00143	CcSEcCtD
Exemestane—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.00143	CcSEcCtD
Exemestane—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00142	CcSEcCtD
Exemestane—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00142	CcSEcCtD
Exemestane—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00142	CcSEcCtD
Exemestane—Prednisone—ALB—chronic obstructive pulmonary disease	0.000108	0.0831	CrCbGaD
Exemestane—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00141	CcSEcCtD
Exemestane—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.0014	CcSEcCtD
Exemestane—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.0811	CrCbGaD
Exemestane—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000105	0.0229	CbGpPWpGaD
Exemestane—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00138	CcSEcCtD
Exemestane—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00137	CcSEcCtD
Exemestane—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00137	CcSEcCtD
Exemestane—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00136	CcSEcCtD
Exemestane—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00136	CcSEcCtD
Exemestane—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.00135	CcSEcCtD
Exemestane—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00135	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.0224	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.0221	CbGpPWpGaD
Exemestane—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00133	CcSEcCtD
Exemestane—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.00132	CcSEcCtD
Exemestane—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0001	0.00132	CcSEcCtD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	9.92e-05	0.0217	CbGpPWpGaD
Exemestane—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.88e-05	0.0013	CcSEcCtD
Exemestane—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.88e-05	0.0013	CcSEcCtD
Exemestane—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.82e-05	0.00129	CcSEcCtD
Exemestane—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.72e-05	0.00128	CcSEcCtD
Exemestane—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.68e-05	0.00128	CcSEcCtD
Exemestane—Estrone—ALB—chronic obstructive pulmonary disease	9.61e-05	0.0742	CrCbGaD
Exemestane—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.56e-05	0.00126	CcSEcCtD
Exemestane—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.56e-05	0.00126	CcSEcCtD
Exemestane—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.46e-05	0.00125	CcSEcCtD
Exemestane—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.00124	CcSEcCtD
Exemestane—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.36e-05	0.00123	CcSEcCtD
Exemestane—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.33e-05	0.00123	CcSEcCtD
Exemestane—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.24e-05	0.00122	CcSEcCtD
Exemestane—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.24e-05	0.00122	CcSEcCtD
Exemestane—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.22e-05	0.0201	CbGpPWpGaD
Exemestane—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.05e-05	0.00119	CcSEcCtD
Exemestane—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.03e-05	0.00119	CcSEcCtD
Exemestane—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.88e-05	0.00117	CcSEcCtD
Exemestane—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.88e-05	0.00117	CcSEcCtD
Exemestane—Rash—Formoterol—chronic obstructive pulmonary disease	8.81e-05	0.00116	CcSEcCtD
Exemestane—Rash—Arformoterol—chronic obstructive pulmonary disease	8.81e-05	0.00116	CcSEcCtD
Exemestane—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.8e-05	0.00116	CcSEcCtD
Exemestane—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.8e-05	0.00116	CcSEcCtD
Exemestane—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.00116	CcSEcCtD
Exemestane—Headache—Formoterol—chronic obstructive pulmonary disease	8.75e-05	0.00115	CcSEcCtD
Exemestane—Headache—Arformoterol—chronic obstructive pulmonary disease	8.75e-05	0.00115	CcSEcCtD
Exemestane—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.72e-05	0.00115	CcSEcCtD
Exemestane—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.7e-05	0.00115	CcSEcCtD
Exemestane—Rash—Montelukast—chronic obstructive pulmonary disease	8.63e-05	0.00114	CcSEcCtD
Exemestane—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.62e-05	0.00114	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	8.62e-05	0.0188	CbGpPWpGaD
Exemestane—Depression—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.00113	CcSEcCtD
Exemestane—Headache—Montelukast—chronic obstructive pulmonary disease	8.57e-05	0.00113	CcSEcCtD
Exemestane—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00112	CcSEcCtD
Exemestane—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	8.45e-05	0.00111	CcSEcCtD
Exemestane—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	8.45e-05	0.00111	CcSEcCtD
Exemestane—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.39e-05	0.0011	CcSEcCtD
Exemestane—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.0011	CcSEcCtD
Exemestane—Rash—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.0011	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.32e-05	0.0182	CbGpPWpGaD
Exemestane—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.00109	CcSEcCtD
Exemestane—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.3e-05	0.00109	CcSEcCtD
Exemestane—Nausea—Formoterol—chronic obstructive pulmonary disease	8.3e-05	0.00109	CcSEcCtD
Exemestane—Headache—Salbutamol—chronic obstructive pulmonary disease	8.26e-05	0.00109	CcSEcCtD
Exemestane—Nausea—Montelukast—chronic obstructive pulmonary disease	8.13e-05	0.00107	CcSEcCtD
Exemestane—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8e-05	0.00105	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	7.84e-05	0.0171	CbGpPWpGaD
Exemestane—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.84e-05	0.00103	CcSEcCtD
Exemestane—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.00102	CcSEcCtD
Exemestane—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.74e-05	0.00102	CcSEcCtD
Exemestane—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000996	CcSEcCtD
Exemestane—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.0164	CbGpPWpGaD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.45e-05	0.0163	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.36e-05	0.0161	CbGpPWpGaD
Exemestane—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.000963	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	7.21e-05	0.0157	CbGpPWpGaD
Exemestane—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.99e-05	0.000921	CcSEcCtD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	6.93e-05	0.0151	CbGpPWpGaD
Exemestane—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000901	CcSEcCtD
Exemestane—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000901	CcSEcCtD
Exemestane—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.79e-05	0.000895	CcSEcCtD
Exemestane—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000893	CcSEcCtD
Exemestane—Pain—Prednisolone—chronic obstructive pulmonary disease	6.47e-05	0.000852	CcSEcCtD
Exemestane—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	6.26e-05	0.0137	CbGpPWpGaD
Exemestane—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.000821	CcSEcCtD
Exemestane—Malaise—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.0008	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.04e-05	0.0132	CbGpPWpGaD
Exemestane—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	6.01e-05	0.0131	CbGpPWpGaD
Exemestane—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.01e-05	0.000792	CcSEcCtD
Exemestane—Testosterone—ALB—chronic obstructive pulmonary disease	5.84e-05	0.0451	CrCbGaD
Exemestane—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000766	CcSEcCtD
Exemestane—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000755	CcSEcCtD
Exemestane—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000755	CcSEcCtD
Exemestane—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000753	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.7e-05	0.0124	CbGpPWpGaD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.00075	CcSEcCtD
Exemestane—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.57e-05	0.000734	CcSEcCtD
Exemestane—Oedema—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000724	CcSEcCtD
Exemestane—Infection—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000719	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.00071	CcSEcCtD
Exemestane—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000703	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.32e-05	0.0116	CbGpPWpGaD
Exemestane—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.0007	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.25e-05	0.0115	CbGpPWpGaD
Exemestane—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.00069	CcSEcCtD
Exemestane—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.0114	CbGpPWpGaD
Exemestane—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.04e-05	0.011	CbGpPWpGaD
Exemestane—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.00066	CcSEcCtD
Exemestane—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5e-05	0.000659	CcSEcCtD
Exemestane—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000655	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.00065	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000637	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000629	CcSEcCtD
Exemestane—Rash—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000628	CcSEcCtD
Exemestane—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000628	CcSEcCtD
Exemestane—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.74e-05	0.000624	CcSEcCtD
Exemestane—Headache—Prednisolone—chronic obstructive pulmonary disease	4.74e-05	0.000624	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	4.72e-05	0.0103	CbGpPWpGaD
Exemestane—Constipation—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000619	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000597	CcSEcCtD
Exemestane—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000592	CcSEcCtD
Exemestane—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.49e-05	0.000592	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.42e-05	0.00965	CbGpPWpGaD
Exemestane—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000575	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.00952	CbGpPWpGaD
Exemestane—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000572	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000572	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000533	CcSEcCtD
Exemestane—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.00052	CcSEcCtD
Exemestane—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000512	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000495	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.74e-05	0.00816	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	3.7e-05	0.00809	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.68e-05	0.00805	CbGpPWpGaD
Exemestane—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000479	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.63e-05	0.00794	CbGpPWpGaD
Exemestane—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.00046	CcSEcCtD
Exemestane—Rash—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000457	CcSEcCtD
Exemestane—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000456	CcSEcCtD
Exemestane—Headache—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.000454	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.00739	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.34e-05	0.00729	CbGpPWpGaD
Exemestane—Nausea—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.00043	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.00701	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	3.19e-05	0.00698	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.17e-05	0.00691	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.06e-05	0.00669	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.99e-05	0.00654	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.95e-05	0.00645	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	2.69e-05	0.00588	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	2.58e-05	0.00564	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.43e-05	0.0053	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.00475	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.00469	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.00402	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.00385	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.71e-05	0.00374	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.7e-05	0.0037	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.67e-05	0.00364	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	1.66e-05	0.00363	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.55e-05	0.00339	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.55e-05	0.00338	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.53e-05	0.00335	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.00328	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.00282	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.27e-05	0.00278	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.26e-05	0.00275	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.00269	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.00235	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.00232	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.88e-06	0.00216	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.74e-06	0.00213	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.37e-06	0.00205	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.24e-06	0.00202	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.09e-06	0.00199	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.98e-06	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.38e-06	0.00183	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.2e-06	0.00179	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.55e-06	0.00165	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.54e-06	0.00165	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.3e-06	0.00138	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.21e-06	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.79e-06	0.00126	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.49e-06	0.0012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.99e-06	0.00109	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.86e-06	0.00106	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.51e-06	0.000986	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.73e-06	0.000815	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.57e-06	0.000779	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.65e-06	0.000579	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.62e-06	0.000573	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.39e-06	0.000523	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.2e-06	0.000481	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-06	0.000402	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-06	0.000396	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-06	0.000369	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-06	0.00035	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-06	0.000238	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-06	0.000227	CbGpPWpGaD
